The cost of developing a drug has doubled, as has the number of clinical trials necessary to file a new drug application.
Today's hearing provides us with an opportunity to examine an important aspect of the 21st Century Cures Initiative.
To help close this innovation gap, as part of 21st Century Cures Initiative, we must take a fresh look at the challenges facing innovative c...
I am particularly interested in better understanding what we can do to make it more attractive for companies and venture capitalists to inve...
Representative McKinley has authored H.R. 4673, a bill that would combine the various post-acute care payments into one reimbursement paymen...
Representatives Mike Rogers and Doris Matsui introduced H.R. 2869, a proposal that would require Medicare to pay for cancer services at the ...
I and Ranking Member Pallone felt it important for the members of this subcommittee to hear the pros and cons of potential policies in this ...
Today's hearing is designed to educate members on a topic that has come up repeatedly in recent years: site-neutral payments.
I know people who have died of this rare disease. It is a terrible disease, and yet not once did anyone ever mention at that hearing the pos...
I urge the committee to address this crisis head-on, and encourage meaningful development in the antibiotic space.
Through this effort, Congress hopes to clear a path to find more cures and treatments while also creating jobs and keeping America as the in...